Episode 77: The Uromigos Paper of the Month – Nadofaragene for BCG unresponsive NMIBC

Stephen Boorjian outlines his recent Lancet oncology paper.

Tom and Brian struggle to keep up.

Related Episodes

Episode 169: The Uromigos Paper of the Month – Novel neoadjuvant approaches in UC
Episode 165: Paper of the Month – ENZAMET quality of life data
Paper of the month: what can we learn from R3 ipilimumab/nivolumab in gastric cancer
Episode 152: The Uromigos Paper of the Month – Zr-Pembrolizumab PET Imaging
Episode 143: The Uromigos Paper of the Month – Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
Episode 140: Ipilimumab in renal cancer
Episode 139: The Uromigos Paper of the Month – Talazoparib in biomarker positive prostate cancer
Episode 125: The Uromigos Paper of the Month – MRI screening for prostate cancer
Episode 101: The Uromigos Paper of the Month – Belzutifan in renal cancer
Episode 97: Sacituzumab Govitecan